These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 24189280

  • 1. Prednisone in lupus nephritis: how much is enough?
    Ruiz-Irastorza G, Danza A, Perales I, Villar I, Garcia M, Delgado S, Khamashta M.
    Autoimmun Rev; 2014 Feb; 13(2):206-14. PubMed ID: 24189280
    [Abstract] [Full Text] [Related]

  • 2. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
    Ruiz-Irastorza G, Ugarte A, Saint-Pastou Terrier C, Lazaro E, Iza A, Couzi L, Saenz R, Richez C, Porta S, Blanco P.
    Autoimmun Rev; 2017 Aug; 16(8):826-832. PubMed ID: 28564619
    [Abstract] [Full Text] [Related]

  • 3. Comparison of high versus low-medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis.
    Ruiz-Arruza I, Barbosa C, Ugarte A, Ruiz-Irastorza G.
    Autoimmun Rev; 2015 Oct; 14(10):875-9. PubMed ID: 26044819
    [Abstract] [Full Text] [Related]

  • 4. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Baldovino S, Menegatti E, La Grotta R, Modena V.
    Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
    [Abstract] [Full Text] [Related]

  • 5. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
    Gonzalez-Echavarri C, Pernas B, Ugarte A, Ruiz-Irastorza G.
    Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
    [Abstract] [Full Text] [Related]

  • 6. Remission of refractory lupus nephritis with a protocol including rituximab.
    Fra GP, Avanzi GC, Bartoli E.
    Lupus; 2003 Mar; 12(10):783-7. PubMed ID: 14596429
    [Abstract] [Full Text] [Related]

  • 7. Prolonged remission in SLE is possible by using reduced doses of prednisone: An observational study from the Lupus-Cruces and Lupus-Bordeaux inception cohorts.
    Ruiz-Irastorza G, Ruiz-Estevez B, Lazaro E, Ruiz-Arruza I, Duffau P, Martin-Cascon M, Richez C, Ugarte A, Blanco P.
    Autoimmun Rev; 2019 Sep; 18(9):102359. PubMed ID: 31323362
    [Abstract] [Full Text] [Related]

  • 8. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
    Liu Z, Zhang H, Liu Z, Xing C, Fu P, Ni Z, Chen J, Lin H, Liu F, He Y, He Y, Miao L, Chen N, Li Y, Gu Y, Shi W, Hu W, Liu Z, Bao H, Zeng C, Zhou M.
    Ann Intern Med; 2015 Jan 06; 162(1):18-26. PubMed ID: 25383558
    [Abstract] [Full Text] [Related]

  • 9. Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis.
    Bitencourt Dias C, Pinheiro CC, Malafronte P, Titan S, Alves de Brito G, Gera Abrão J, Dos Santos Silva V, Toledo Barros R, Woronik V.
    Clin Nephrol; 2011 Jul 06; 76(1):57-63. PubMed ID: 21722606
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug 06; 130 Suppl 3():19-25. PubMed ID: 12583309
    [Abstract] [Full Text] [Related]

  • 11. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial.
    Zhang M, Qi C, Zha Y, Chen J, Luo P, Wang L, Sun Z, Wan J, Xing C, Wang S, Jiang G, Sun M, Chen Q, Chen J, Li D, Guan T, Ni Z.
    Clin Rheumatol; 2019 Mar 06; 38(3):859-867. PubMed ID: 30426311
    [Abstract] [Full Text] [Related]

  • 12. Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study.
    Hu WX, Chen YH, Bao H, Liu ZZ, Wang SF, Zhang HT, Liu ZH.
    Lupus; 2015 Sep 06; 24(10):1067-75. PubMed ID: 25819933
    [Abstract] [Full Text] [Related]

  • 13. Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study.
    Mehra S, Usdadiya JB, Jain VK, Misra DP, Negi VS.
    Rheumatol Int; 2018 Apr 06; 38(4):557-568. PubMed ID: 29450636
    [Abstract] [Full Text] [Related]

  • 14. Eurolupus cyclophosphamide plus repeated pulses of methyl-prednisolone for the induction therapy of class III, IV and V lupus nephritis.
    Ruiz-Irastorza G, Dueña-Bartolome L, Dunder S, Varona J, Gomez-Carballo C, Dominguez-Cainzos J, Rodrigo-Manjon A, Bueno L, Richez C, Duffau P, Blanco P, Lazaro E.
    Autoimmun Rev; 2021 Oct 06; 20(10):102898. PubMed ID: 34274543
    [Abstract] [Full Text] [Related]

  • 15. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.
    Illei GG, Austin HA, Crane M, Collins L, Gourley MF, Yarboro CH, Vaughan EM, Kuroiwa T, Danning CL, Steinberg AD, Klippel JH, Balow JE, Boumpas DT.
    Ann Intern Med; 2001 Aug 21; 135(4):248-57. PubMed ID: 11511139
    [Abstract] [Full Text] [Related]

  • 16. Seventy years after Hench's Nobel prize: revisiting the use of glucocorticoids in systemic lupus erythematosus.
    Ruiz-Irastorza G, Ugarte A, Ruiz-Arruza I, Khamashta M.
    Lupus; 2020 Sep 21; 29(10):1155-1167. PubMed ID: 32539657
    [Abstract] [Full Text] [Related]

  • 17. Medium Versus High Initial Prednisone Dose for Remission Induction in Lupus Nephritis: A Propensity Score-Matched Analysis.
    Tselios K, Gladman DD, Al-Sheikh H, Su J, Urowitz MB.
    Arthritis Care Res (Hoboken); 2022 Sep 21; 74(9):1451-1458. PubMed ID: 33662177
    [Abstract] [Full Text] [Related]

  • 18. The short-term efficacy of bortezomib combined with glucocorticoids for the treatment of refractory lupus nephritis.
    Zhang H, Liu Z, Huang L, Hou J, Zhou M, Huang X, Hu W, Liu Z.
    Lupus; 2017 Aug 21; 26(9):952-958. PubMed ID: 28059023
    [Abstract] [Full Text] [Related]

  • 19. Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome).
    Calguneri M, Ozbalkan Z, Ozturk MA, Apras S, Ertenli AI, Kiraz S.
    Clin Rheumatol; 2006 Nov 21; 25(6):782-8. PubMed ID: 16547692
    [Abstract] [Full Text] [Related]

  • 20. Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis.
    Kasitanon N, Fine DM, Haas M, Magder LS, Petri M.
    Lupus; 2006 Nov 21; 15(6):366-70. PubMed ID: 16830883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.